Benitec Biopharma Inc.BNTCNASDAQ

Revenue (LTM)

Net Income (LTM)

$-38M

-74.3% YoY

Free Cash Flow

$-24M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Revenue	0	0↑23.7%	0↑2.7%	0	0
Gross Profit	-0	0↑200.0%	-0↓578.1%	-0↓12.1%	-0↓15.5%
Operating Income	-14	-18↓31.3%	-19↓6.9%	-23↓18.4%	-42↓84.8%
Net Income	-14	-18↓31.2%	-20↓7.4%	-22↓11.2%	-38↓74.3%
EBITDA	-13	-18↓32.7%	-19↓7.2%	-21↓11.8%	-42↓94.8%
EPS Diluted	-27.27	-19.31↑29.2%	-14.12↑26.9%	-2.68↑81.0%	-1.05↑60.8%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Cash & Equivalents	20	4↓79.5%	2↓39.0%	51↑1953.5%	98↑92.2%
Total Current Assets	21	5↓76.6%	4↓22.6%	52↑1285.7%	99↑90.7%
Total Assets	21	6↓72.1%	4↓25.3%	52↑1069.6%	100↑90.8%
Total Current Liabilities	1	3↑85.0%	4↑57.1%	5↑23.8%	2↓63.4%
Total Liabilities	1	3↑125.8%	4↑37.9%	5↑16.4%	2↓53.7%
Total Equity	20	3↓85.6%	0↓93.0%	47↑23290.1%	97↑105.9%
Total Debt	0	1↑280.8%	1↓31.1%	0↓49.2%	1↑198.9%
Net Debt	-20	-3↑83.4%	-2↑41.0%	-51↓2537.2%	-97↓91.6%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Operating Cash Flow	-13	-16↓23.9%	-18↓13.3%	-19↓7.7%	-24↓21.6%
Capital Expenditure	-0	-0↑94.1%	-0↑92.3%	-0↓17800.0%	-0↑89.9%
Free Cash Flow	-13	-16↓21.9%	-18↓13.2%	-20↓8.7%	-24↓20.5%
Stock-Based Comp	1	1↑37.2%	0↓48.0%	1↑83.6%	17↑1999.5%
Net Change in Cash	10	-16↓257.6%	-2↑89.9%	48↑3154.2%	47↓3.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance